Multiple myeloma: patient outcomes in real‐world practice von Yong, Kwee, Delforge, Michel, Driessen, Christoph, Fink, Leah, Flinois, Alain, Gonzalez‐McQuire, Sebastian, Safaei, Reza, Karlin, Lionel, Mateos, Maria‐Victoria, Raab, Marc S., Schoen, Paul, Cavo, Michele

Volltext

Novel immunotherapies in multiple myeloma - chances and challenges von Rasche, Leo, Wasch, Ralph, Munder, Markus, Goldschmidt, Hartmut, Raab, Marc S.

Volltext

The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma von Rasche, Leo, Kortüm, K Martin, Raab, Marc S, Weinhold, Niels

Volltext

Long‐Term Behavior of a Solid Oxide Electrolyzer (SOEC) Stack von Lang, M., Raab, S., Lemcke, M. S., Bohn, C., Pysik, M.

Volltext

Progression in Smoldering Myeloma Is Independently Determined by the Chromosomal Abnormalities del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load von NEBEN, Kai, JAUCH, Anna, HOSE, Dirk, HIELSCHER, Thomas, HILLENGASS, Jens, LEHNERS, Nicola, SECKINGER, Anja, GRANZOW, Martin, RAAB, Marc S, HO, Anthony D, GOLDSCHMIDT, Hartmut

Volltext

Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics von Tirier, Stephan M., Mallm, Jan-Philipp, Steiger, Simon, Poos, Alexandra M., Awwad, Mohamed H. S., Giesen, Nicola, Casiraghi, Nicola, Susak, Hana, Bauer, Katharina, Baumann, Anja, John, Lukas, Seckinger, Anja, Hose, Dirk, Müller-Tidow, Carsten, Goldschmidt, Hartmut, Stegle, Oliver, Hundemer, Michael, Weinhold, Niels, Raab, Marc S., Rippe, Karsten

Volltext

Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes von Kortüm, K.Martin, Mai, Elias K., Hanafiah, Nur H., Shi, Chang-Xi, Zhu, Yuan-Xiao, Bruins, Laura, Barrio, Santiago, Jedlowski, Patrick, Merz, Maximilian, Xu, Jing, Stewart, Robert A., Andrulis, Mindaugas, Jauch, Anna, Hillengass, Jens, Goldschmidt, Hartmut, Bergsagel, P.Leif, Braggio, Esteban, Stewart, A.Keith, Raab, Marc S.

Volltext

Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients von Weinhold, Niels, Salwender, Hans J., Cairns, David A., Raab, Marc S., Waldron, George, Blau, Igor W., Bertsch, Uta, Hielscher, Thomas, Morgan, Gareth J., Jauch, Anna, Davies, Faith E., Hanel, Mathias, Cook, Gordon, Scheid, Christoph, Houlston, Richard, Goldschmidt, Hartmut, Jackson, Graham, Kaiser, Martin F.

Volltext

Multiple myeloma von Raab, Marc S, MD, Podar, Klaus, MD, Breitkreutz, Iris, MD, Richardson, Paul G, MD, Anderson, Kenneth C, Prof

Volltext

Multiple myeloma: practice patterns across Europe von Raab, Marc S., Cavo, Michele, Delforge, Michel, Driessen, Christoph, Fink, Leah, Flinois, Alain, Gonzalez‐McQuire, Sebastian, Safaei, Reza, Karlin, Lionel, Mateos, Maria‐Victoria, Schoen, Paul, Yong, Kwee

Volltext

Targeting the BRAF V600E mutation in multiple myeloma von Andrulis, Mindaugas, Lehners, Nicola, Capper, David, Penzel, Roland, Heining, Christoph, Huellein, Jennifer, Zenz, Thorsten, von Deimling, Andreas, Schirmacher, Peter, Ho, Anthony D, Goldschmidt, Hartmut, Neben, Kai, Raab, Marc S

Volltext

Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma von Weinhold, Niels, Kirn, Desiree, Seckinger, Anja, Hielscher, Thomas, Granzow, Martin, Bertsch, Uta, Egerer, Gerlinde, Salwender, Hans, Blau, Igor W, Weisel, Katja, Hillengass, Jens, Raab, Marc S, Hose, Dirk, Goldschmidt, Hartmut, Jauch, Anna

Volltext

Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition von Raab, Marc S., Lehners, Nicola, Xu, Jing, Ho, Anthony D., Schirmacher, Peter, Goldschmidt, Hartmut, Andrulis, Mindaugas

Volltext

STIL is required for centriole duplication in human cells von Vulprecht, Julia, David, Ahuvit, Tibelius, Alexandra, Castiel, Asher, Konotop, Gleb, Liu, Fengying, Bestvater, Felix, Raab, Marc S, Zentgraf, Hanswalter, Izraeli, Shai, Krämer, Alwin

Volltext

Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma von Breitkreutz, I, Raab, M S, Vallet, S, Hideshima, T, Raje, N, Mitsiades, C, Chauhan, D, Okawa, Y, Munshi, N C, Richardson, P G, Anderson, K C

Volltext

Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from th... von Kauer, Joseph, Freundt, Emma P, Schmitt, Anita, Weinhold, Niels, Mai, Elias K, Müller-Tidow, Carsten, Goldschmidt, Hartmut, Raab, Marc S, Kriegsmann, Katharina, Sauer, Sandra

Volltext

Real-world analysis of teclistamab in 123 RRMM patients from Germany von Riedhammer, C., Bassermann, F., Besemer, B., Bewarder, M., Brunner, F., Carpinteiro, A., Einsele, H., Faltin, J., Frenking, J., Gezer, D., Goldman-Mazur, S., Hänel, M., Hoegner, M., Kortuem, K. M., Krönke, J., Kull, M., Leitner, T., Mann, C., Mecklenbrauck, R., Merz, M., Morgner, A., Nogai, A., Raab, M. S., Teipel, R., Wäsch, R., Rasche, L.

Volltext

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial von Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Mai, Elias K, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W, Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S, Schurich, Baerbel, Munder, Markus, Schmidt-Wolf, Ingo G H, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut

Volltext

Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities von Giesen, Nicola, Paramasivam, Nagarajan, Toprak, Umut H, Huebschmann, Daniel, Xu, Jing, Uhrig, Sebastian, Samur, Mehmet, Bähr, Stella, Fröhlich, Martina, Mughal, Sadaf S, Mai, Elias K, Jauch, Anna, Müller-Tidow, Carsten, Brors, Benedikt, Munshi, Nikhil, Goldschmidt, Hartmut, Weinhold, Niels, Schlesner, Matthias, Raab, Marc S

Volltext

Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients underg... von NEBEN, Kai, JAUCH, Anna, HO, Anthony D, HOSE, Dirk, GOLDSCHMIDT, Hartmut, BERTSCH, Uta, HEISS, Christiane, HIELSCHER, Thomas, SECKINGER, Anja, MORS, Tina, MÜLLER, Nadine Zoe, HILLENGASS, Jens, RAAB, Marc S

Volltext